ERBB2 and metastatic malignant neoplasm in the lymph nodes: We revealed a novel mechanism of the β2-AR upregulation in Her2-overexpressing breast cancer and demonstrated that high level of β2-AR is associated with lymph node metastasis and poor prognosis in Her2-positive breast cancer patients.